Semi-Annual Consolidated Statement Of Income

Fuso Pharmaceutical Industries,Ltd. - Filing #7329099

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Semi-annual consolidated statement of income
Statement of income
Net sales
55,407,000,000 JPY
51,015,000,000 JPY
Cost of sales
41,568,000,000 JPY
37,275,000,000 JPY
Ordinary profit (loss)
1,868,000,000 JPY
2,215,000,000 JPY
Gross profit (loss)
13,838,000,000 JPY
13,740,000,000 JPY
Extraordinary income
39,000,000 JPY
JPY
Selling, general and administrative expenses
Salaries
2,354,000,000 JPY
2,388,000,000 JPY
Depreciation
321,000,000 JPY
379,000,000 JPY
Selling, general and administrative expenses
11,874,000,000 JPY
11,533,000,000 JPY
Extraordinary losses
140,000,000 JPY
10,000,000 JPY
Profit (loss) before income taxes
1,767,000,000 JPY
2,205,000,000 JPY
Operating profit (loss)
1,964,000,000 JPY
2,206,000,000 JPY
Income taxes - current
425,000,000 JPY
519,000,000 JPY
Non-operating income
Non-operating income
232,000,000 JPY
390,000,000 JPY
Income taxes - deferred
-35,000,000 JPY
80,000,000 JPY
Non-operating expenses
Interest expenses
171,000,000 JPY
165,000,000 JPY
Non-operating expenses
328,000,000 JPY
380,000,000 JPY
Income taxes
389,000,000 JPY
599,000,000 JPY
Profit (loss)
1,377,000,000 JPY
1,377,000,000 JPY
1,377,000,000 JPY
1,377,000,000 JPY
1,605,000,000 JPY
1,605,000,000 JPY
1,605,000,000 JPY
1,605,000,000 JPY
Extraordinary income
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.